Basit öğe kaydını göster

Bone and renal safety are improved in chronic HBV patients switched to tenofovir alafenamide (TAF) after either 2 or 3 years of prior tenofovir disoproxil fumarate (TDF) treatment

dc.contributor.authorKao, Jia-Horng
dc.contributor.authorFehmi, Tabak
dc.contributor.authorButi, Maria
dc.contributor.authorIzumi, Namiki
dc.contributor.authorLim, Young-Suk
dc.contributor.authorJanssen, Harry
dc.contributor.authorStreinu-Cercel, Adrian
dc.contributor.authorMa, Xiaoli
dc.contributor.authorNurmukhametova, Elena
dc.contributor.authorJablkowski, Maciej
dc.contributor.authorSuri, Vithika
dc.contributor.authorFlaherty, John F.
dc.contributor.authorLau, Audrey
dc.contributor.authorGaggar, Anuj
dc.contributor.authorMo, Shuyuan
dc.contributor.authorChaudhuri, Abhijit
dc.contributor.authorFung, Scott
dc.contributor.authorChuang, Wan-Long
dc.contributor.authorGane, Edward
dc.date.accessioned2021-03-03T10:20:22Z
dc.date.available2021-03-03T10:20:22Z
dc.identifier.citationButi M., Izumi N., Lim Y., Janssen H., Kao J., Streinu-Cercel A., Nurmukhametova E., Ma X., Fehmi T., Jablkowski M., et al., "Bone and renal safety are improved in chronic HBV patients switched to tenofovir alafenamide (TAF) after either 2 or 3 years of prior tenofovir disoproxil fumarate (TDF) treatment", International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, Avusturya, 10 - 14 Nisan 2019, cilt.70
dc.identifier.otherav_220bd428-9af7-4beb-946a-53108a8adc33
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/27896
dc.identifier.urihttps://doi.org/10.1016/s0618-8278(19)30903-x
dc.language.isoeng
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectGastroenteroloji-(Hepatoloji)
dc.titleBone and renal safety are improved in chronic HBV patients switched to tenofovir alafenamide (TAF) after either 2 or 3 years of prior tenofovir disoproxil fumarate (TDF) treatment
dc.typeBildiri
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume70
dc.contributor.firstauthorID156023


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster